Dr. Hsing-Jung Chen-Engerer Dr. Hsing-Jung Chen-Engerer Prioritizing development with Dr. Hsing-Jung Chen-Engerer
Chickenwrap video Chickenwrap video This spicy, zingy chicken wrap is great for the whole family. Watch this video to learn how to make it.
Baked Stuffed Apples Video Baked Stuffed Apples Video Our baked stuffed apple with nuts, dried fruit, blackberries and yogurt is a perfect speedy dessert full of fruit and fibre.
Honey Icecream Video Honey Icecream Video This dessert is perfectly balanced with juicy pineapple, smooth honey ice cream and crunchy walnut pieces.
Practical Advice Practical Advice Practical advice for people with type 2 diabetes (T2D) at risk of heart disease
Mackerel Salad Video Mackerel Salad Video This colourful, fruity salad is full of imaginative flavour combinations, perfect for people with a decreased sense of taste.
Watercress Soup Video Watercress Soup Video This delicate soup is easy to eat with plenty of fragrant flavour. Click here to find out how to make it.
Lamb-shanks video Lamb-shanks video This succulent, heart dish is packed full of flavour and sure to be a hit with the whole family.
Building Lasting Partnerships for a Better Future Building Lasting Partnerships for a Better Future Working with the University of Georgia, we’ve co-created a sustainability training initiative that benefits people, animals and the planet.
Patient explains how IPF affects his life Patient explains how IPF affects his life A patient with moderate IPF explains how the disease affects his every day life. Learn more here.
BTD for GlyT1 in Schizophrenia BTD for GlyT1 in Schizophrenia Boehringer Ingelheim’s Investigational Treatment for Cognitive Impairment Associated with Schizophrenia receives FDA Breakthrough Therapy Designation
reduced-heart-failure-treatment-approval-europe reduced-heart-failure-treatment-approval-europe European approval for treatment of adults with heart failure with reduced ejection fraction
new_analysis_nintedanib_SSc_ILD new_analysis_nintedanib_SSc_ILD Interim analysis results support long term treatment with nintedanib in SSc-ILD patients
empa-reg-outcome-recurrent-events empa-reg-outcome-recurrent-events EMPA-REG OUTCOME® analysis: Empagliflozin reduced risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and CV disease
Reduction of Salmonella in swine after vaccination Reduction of Salmonella in swine after vaccination Authorities acknowledge reduction of Salmonella after vaccination with Enterisol® Ileitis
Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD FDA Grants nintedanib Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
GioTag Final Data GioTag Final Data Final analysis of GioTag study data showed sequential afatinib followed by osimertinib is a feasible therapeutic strategy in EGFR M+ NSCLC patients
biolabs-heidelberg biolabs-heidelberg Boehringer Ingelheim supports the launch of BioLabs first European Location in Heidelberg.